Quantbot Technologies LP Has $3.61 Million Stock Holdings in Vital Farms, Inc. $VITL

Quantbot Technologies LP reduced its position in shares of Vital Farms, Inc. (NASDAQ:VITL) by 26.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 87,722 shares of the company’s stock after selling 30,935 shares during the period. Quantbot Technologies LP owned about 0.20% of Vital Farms worth $3,610,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Exchange Traded Concepts LLC acquired a new stake in Vital Farms during the 3rd quarter worth approximately $28,000. Assetmark Inc. raised its stake in shares of Vital Farms by 18.9% during the second quarter. Assetmark Inc. now owns 3,153 shares of the company’s stock valued at $121,000 after acquiring an additional 501 shares during the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Vital Farms by 53.6% during the third quarter. Jones Financial Companies Lllp now owns 3,197 shares of the company’s stock worth $135,000 after purchasing an additional 1,116 shares during the period. US Bancorp DE grew its stake in shares of Vital Farms by 48.3% in the third quarter. US Bancorp DE now owns 3,369 shares of the company’s stock worth $139,000 after purchasing an additional 1,098 shares during the last quarter. Finally, State of Wyoming acquired a new stake in Vital Farms in the second quarter valued at $141,000. Institutional investors own 98.59% of the company’s stock.

Vital Farms News Roundup

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Q4 revenue growth and top‑line clarity — Revenue rose ~28.6% year‑over‑year and Q4 revenue came in essentially inline with expectations, showing continued demand and scale benefits. This supports the company’s growth story even though EPS missed. MarketBeat / Press Release
• Neutral Sentiment: Board leadership transition — Founder Matt O’Hayer stepped down as Executive Chair; CEO Russell Diez‑Canseco was named Executive Chair to maintain continuity. This reduces governance uncertainty short‑term but is unlikely to change fundamentals immediately. Business Wire
• Negative Sentiment: EPS miss and mixed guidance reaction — Q4 EPS of $0.35 missed the $0.38 consensus (revenues roughly inline). Several outlets highlight the profit shortfall and guidance interpretation that disappointed some investors, which directly pressured the stock. Zacks
• Negative Sentiment: Securities‑class investigation announced — The Rosen Law Firm has opened an investigation alleging Vital Farms may have provided materially misleading information to investors. Such filings often increase short‑term selling pressure and can raise legal risk and potential future costs. GlobeNewswire
• Negative Sentiment: Analyst revisions and target cuts — Multiple firms updated coverage: Benchmark downgraded to “hold,” Morgan Stanley trimmed its price target to $24 (from $45), and Telsey cut its target to $35 while keeping an outperform stance. These moves reduce near‑term upside expectations and can amplify selling. Benzinga

Insider Activity

In other news, insider Matthew Ohayer sold 25,000 shares of the stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $30.85, for a total transaction of $771,250.00. Following the transaction, the insider owned 6,361,190 shares of the company’s stock, valued at $196,242,711.50. This represents a 0.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Russell Diez-Canseco sold 16,734 shares of the business’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $35.05, for a total value of $586,526.70. Following the completion of the sale, the chief executive officer directly owned 649,684 shares of the company’s stock, valued at $22,771,424.20. The trade was a 2.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 66,734 shares of company stock worth $2,092,227 in the last quarter. Company insiders own 21.30% of the company’s stock.

Vital Farms Price Performance

Vital Farms stock opened at $21.09 on Monday. The stock has a market capitalization of $944.83 million, a price-to-earnings ratio of 14.65 and a beta of 1.14. Vital Farms, Inc. has a 52-week low of $19.80 and a 52-week high of $53.13. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.61 and a current ratio of 2.16. The stock’s 50 day moving average price is $28.60 and its two-hundred day moving average price is $35.98.

Vital Farms (NASDAQ:VITL) last released its earnings results on Thursday, February 26th. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.03). The company had revenue of $213.55 million for the quarter, compared to analyst estimates of $212.83 million. Vital Farms had a net margin of 8.73% and a return on equity of 20.69%. The firm’s revenue was up 28.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.23 EPS. On average, equities analysts predict that Vital Farms, Inc. will post 1.11 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have commented on the company. TD Cowen reaffirmed a “buy” rating on shares of Vital Farms in a report on Tuesday, January 20th. Needham & Company LLC restated a “buy” rating and set a $45.00 price objective on shares of Vital Farms in a research report on Friday, January 30th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $52.00 price objective on shares of Vital Farms in a research note on Wednesday, December 17th. Telsey Advisory Group decreased their target price on shares of Vital Farms from $50.00 to $35.00 and set an “outperform” rating for the company in a research report on Friday. Finally, DA Davidson set a $47.00 price target on shares of Vital Farms and gave the stock a “buy” rating in a report on Wednesday, December 17th. Nine analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, Vital Farms has a consensus rating of “Moderate Buy” and an average target price of $46.64.

Vital Farms Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.